Technology
TECHNOLOGY ADVANTAGE
Stemedica uses proprietary processes and procedures for manufacturing and master banking best-in-class adult stem cell lines. Our technology advantages include:
Safety -- We follow quality control and safety monitoring and measurement protocols that follow FDA/cGMP guidelines for infectious diseases, acute and chronic toxicity and tumorgenicity. Proprietary Master Banking processes also insure cell preservation and viability.
Consistency -- Cells produced by Stemedica measure high for quality and consistency. Stem cells have remained reliable, potent and have kept their migratory properties from lot to lot.
Scalability -- One single cell can be reproduced 1,000x, compared to the industry-average of 10x, increasing the number of potential treatments. These cells can migrate without losing stability, purity or potency in the body.
Capability -- We have one of the largest manufacturing capacities in the industry to produce multiple cell lines. Currently we produce mesenchymal stem cells, neural stem cells and retinal pigment epithelial progenitor cells.
Capacity -- We have one of the largest manufacturing capacities in the industry with advanced facilities spanning three continents that staff highly skilled technicians.
Licensed -- Our San Diego, California manufacturing facility is FDA cGMP-compliant and licensed to produce products/cells for clinical (human) trials.